137 related articles for article (PubMed ID: 6298121)
1. Characterization of stable spontaneous metastatic variant lines of RSV-transformed mouse fibroblasts.
Di Renzo MF; Bretti S
Int J Cancer; 1982 Dec; 30(6):751-7. PubMed ID: 6298121
[TBL] [Abstract][Full Text] [Related]
2. Organization of cytoskeleton and fibronectin matrix in Rous sarcoma virus (RSV)-transformed fibroblast lines with different metastatic potential.
Di Renzo MF; Tarone G; Comoglio PM; Marchisio PC
Eur J Cancer Clin Oncol; 1985 Jan; 21(1):85-96. PubMed ID: 2982623
[TBL] [Abstract][Full Text] [Related]
3. Lipid characteristics of RSV-transformed Balb/c 3T3 cell lines with different spontaneous metastatic potentials.
Calorini L; Fallani A; Tombaccini D; Barletta E; Mugnai G; Di Renzo MF; Comoglio PM; Ruggieri S
Lipids; 1989 Aug; 24(8):685-90. PubMed ID: 2555644
[TBL] [Abstract][Full Text] [Related]
4. Metastatic clones selected from an RSV-induced mouse sarcoma share a common marker chromosome.
Di Renzo MF; Doneda L; Larizza L; Comoglio PM
Int J Cancer; 1983 Apr; 31(4):455-61. PubMed ID: 6299976
[TBL] [Abstract][Full Text] [Related]
5. High chemotactic motility and growth in hard agar of a variant of RSV-transformed fibroblasts are lost in late passages.
Allavena G; Melchiori A; Carlone S; Di Renzo MF; Comoglio P; Parodi S; Santi L; Albini A
Tumori; 1988 Feb; 74(1):1-6. PubMed ID: 2832985
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tumorigenic and metastatic properties of murine sarcoma virus-transformed nonproducer Balb/3T3 cell lines.
Yogeeswaran G; Stein BS; Sebastian H
J Natl Cancer Inst; 1980 Apr; 64(4):951-7. PubMed ID: 6245299
[No Abstract] [Full Text] [Related]
7. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
[TBL] [Abstract][Full Text] [Related]
8. Metastasizing fibrosarcomas in hamsters (BMH) after injection of B77 sarcoma virus transformed mouse cells.
Sabová L; Smida J; Smidová V
Neoplasma; 1983; 30(6):659-66. PubMed ID: 6318137
[TBL] [Abstract][Full Text] [Related]
9. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma.
Cifone MA; Fidler IJ
Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1039-43. PubMed ID: 6928659
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of neoplastic cells derived from a hamster tumor induced by avian sarcoma virus B77.
Sabová L; Smida J; Smidová V
Neoplasma; 1979; 26(6):641-6. PubMed ID: 232249
[TBL] [Abstract][Full Text] [Related]
11. Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells.
Gronostajski RM; Pardee AB
J Cell Physiol; 1984 Apr; 119(1):127-32. PubMed ID: 6323489
[TBL] [Abstract][Full Text] [Related]
12. Reduction of the metastatic potential of a RSV-transformed fibroblastic line (B77-AA6 cells) upon transplantation in essential fatty acid-deficient mice.
Calorini L; Ruggieri S
Invasion Metastasis; 1992; 12(3-4):233-40. PubMed ID: 1338202
[TBL] [Abstract][Full Text] [Related]
13. Plate-induced tumors of BALB/3T3 cells exhibiting foci of differentiation into pericytes, chondrocytes, and fibroblasts.
Boone CW; Scott RE
J Supramol Struct; 1980; 14(2):233-40. PubMed ID: 7230806
[TBL] [Abstract][Full Text] [Related]
14. No expression of a Rous sarcoma virus-induced tumor antigen in mammalian cells infected with retroviruses transducing other oncogenes of the src gene family.
Kuzumaki N; Yamagiwa S; Oikawa T
J Natl Cancer Inst; 1985 Apr; 74(4):889-92. PubMed ID: 2985859
[TBL] [Abstract][Full Text] [Related]
15. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
16. Clustering of discrete cell properties essential for tumorigenicity and metastasis. II. Studies of Syrian hamster embryo fibroblasts transformed by Rous sarcoma virus.
Deichman GI; Kashleva HA; Kluchareva TE; Matveeva VA
Int J Cancer; 1989 Nov; 44(5):908-10. PubMed ID: 2555309
[TBL] [Abstract][Full Text] [Related]
17. [Differences in the distribution of proviruses in low- and highly- metastatic variants of hamster cells, transformed by Rous sarcoma virus].
Brashishkite DA; Tatosian AG; Kiselev FL; Kashleva EA; Deĭchman GI
Mol Biol (Mosk); 1989; 23(3):758-64. PubMed ID: 2549401
[TBL] [Abstract][Full Text] [Related]
18. Role of heterochromatin variation in the instability of a marker chromosome during tumor progression.
Doneda L; Di Renzo MF; Comoglio PM; Larizza L
Cancer Genet Cytogenet; 1985 Feb; 15(3-4):283-91. PubMed ID: 3971320
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between tumorigenicity and level of plasminogen activator in fibroblasts transformed by Rous sarcoma virus.
Wolf BA; Goldberg AR
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4967-71. PubMed ID: 217007
[TBL] [Abstract][Full Text] [Related]
20. Neoplastic progression evidenced in the L929 cell system. I. Selection of tumorigenic and metastasizing cell variants.
Gavilondo J; Fernandez A; Castillo R; Lage A
Neoplasma; 1982; 29(3):269-79. PubMed ID: 7133224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
